We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-7.92%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$8.14B
AUM Growth
+$473M
Cap. Flow
+$1.3B
Cap. Flow %
15.91%
Top 10 Hldgs %
18.35%
Holding
1,253
New
376
Increased
261
Reduced
225
Closed
366

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$180M
2
ZTS icon
Zoetis
ZTS
+$103M
3
GILD icon
Gilead Sciences
GILD
+$98.1M
4
SHW icon
Sherwin-Williams
SHW
+$85.9M
5
VZ icon
Verizon
VZ
+$79.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.21%
2 Financials 15.39%
3 Communication Services 14.58%
4 Consumer Discretionary 9.63%
5 Industrials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
1
Zoetis
ZTS
$31.3B
$310M 3.8%
7,515,997
+2,214,206
+42% +$103M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$3.89T
$178M 2.19%
+5,575,920
New +$180M
AGN
3
DELISTED
Allergan plc
AGN
$176M 2.17%
648,837
+250,094
+63% +$76.8M
TMUS icon
4
T-Mobile US
TMUS
$183B
$170M 2.09%
4,277,441
+327,918
+8% +$13.1M
SHW icon
5
Sherwin-Williams
SHW
$76.6B
$130M 1.6%
1,754,604
+979,275
+126% +$85.9M
AZO icon
6
AutoZone
AZO
$47.7B
$118M 1.45%
163,482
+77,459
+90% +$54.9M
CMCSA icon
7
Comcast
CMCSA
$78.3B
$116M 1.42%
4,069,756
-1,248,950
-23% -$37.1M
GILD icon
8
Gilead Sciences
GILD
$162B
$102M 1.25%
1,036,927
+883,381
+575% +$98.1M
PFE icon
9
Pfizer
PFE
$143B
$98.8M 1.21%
3,314,705
+1,356,085
+69% +$43.5M
NKE icon
10
Nike
NKE
$60.8B
$94.9M 1.17%
1,543,084
+90,384
+6% +$5.11M
LBTYK icon
11
Liberty Global Class C
LBTYK
$3.37B
$92.8M 1.14%
2,606,688
+504,186
+24% +$20.4M
CVS icon
12
CVS Health
CVS
$136B
$88.4M 1.09%
915,997
+88,016
+11% +$9.25M
CHTR icon
13
Charter Communications
CHTR
$15.6B
$78.4M 0.96%
445,678
+254,171
+133% +$46.4M
VZ icon
14
Verizon
VZ
$183B
$77M 0.95%
1,770,715
+1,730,542
+4,308% +$79.9M
META icon
15
Meta Platforms (Facebook)
META
$1.54T
$76.5M 0.94%
850,905
-10,166
-1% -$933K
MDT icon
16
Medtronic
MDT
$105B
$76.1M 0.93%
1,136,545
-131,311
-10% -$9.67M
JNJ icon
17
Johnson & Johnson
JNJ
$624B
$75.6M 0.93%
809,433
+738,623
+1,043% +$71.5M
LUV icon
18
Southwest Airlines
LUV
$21.9B
$75.2M 0.92%
1,976,518
+1,769,515
+855% +$65.3M
ABT icon
19
Abbott
ABT
$175B
$72.7M 0.89%
1,807,936
+1,328,459
+277% +$62.6M
COO icon
20
Cooper Companies
COO
$13.7B
$71.5M 0.88%
1,919,956
+243,724
+15% +$10.1M
CAH icon
21
Cardinal Health
CAH
$52.9B
$65.8M 0.81%
857,148
+294,530
+52% +$24.6M
LYB icon
22
LyondellBasell Industries
LYB
$19.9B
$64M 0.79%
767,487
-69,182
-8% -$6.15M
LAZ icon
23
Lazard
LAZ
$4.24B
$63.8M 0.78%
1,472,265
+514,931
+54% +$26.5M
C icon
24
Citigroup
C
$221B
$61.5M 0.76%
1,240,434
+13,430
+1% +$734K
BMY icon
25
Bristol-Myers Squibb
BMY
$126B
$61.3M 0.75%
1,035,673
+389,607
+60% +$24.7M

Similar funds

Marshall Wace's Q3 2015 Portfolio in Review

As of Q3 2015, Marshall Wace held 1,253 positions worth $8.14B, up 6.2% from $7.67B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace deployed $1.3B of net new capital in Q3 2015, opening 376 new positions and adding to 261 existing holdings. Its largest new stake was Alphabet (Google) Class A: 5,575,920 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $137M trimmed.

  • Marshall Wace's largest Q3 2015 buy was Alphabet (Google) Class A: 5,575,920 shares worth $178M.
  • Marshall Wace added most to Zoetis in Q3 2015, an estimated $103M increase.
  • Marshall Wace's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $137M.
  • Marshall Wace fully exited Emerson Electric in Q3 2015, selling an estimated $46.3M.
  • Marshall Wace's ten largest holdings make up 18% of its $8.14B portfolio in Q3 2015.
  • Marshall Wace opened 376 new positions and closed 366 in Q3 2015.
  • Marshall Wace's portfolio value rose 6.2% quarter-over-quarter to $8.14B.

Based on Marshall Wace's 13F filing for Q3 2015, filed 12 Nov 2015.